Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience
Patrick P. Bourgouin, Maria M. Wrobel, Nathaniel D. Mercaldo, Mark C. Murphy, Konstantin S. Leppelmann, Vincent M. Levesque, Ashok Muniappan, Stuart G. Silverman, JoAnne O. Shepard, Paul B. Shyn, Florian J. Fintelmann
Abstract
. Percutaneous MWA and cryoablation are both suited for the treatment of sarcoma lung metastases, especially for tumors 1 cm or smaller, whether peripheral or nonperipheral. Complications, if they occur, are not life-threatening.
Topics & Concepts
MedicineMicrowave ablationCryoablationRadiologyPercutaneousSarcomaAblationRetrospective cohort studyLungInterquartile rangeRadiofrequency ablationInterventional radiologyProportional hazards modelLung cancerSurgeryCohortNuclear medicineHazard ratioSurvival rateCancerMalignancyHepatocellular Carcinoma Treatment and PrognosisRenal cell carcinoma treatmentLung Cancer Diagnosis and Treatment